Laliberte RE, Perregaux DG, Hoth LR, Rosner PJ, Jordan CK, Peese KM, Eggler JF, Dombroski MA, Geoghegan KF, Gabel CA: Glutathione s-transferase omega 1-1 is a target of cytokine release inhibitory drugs and may be responsible for their effect on interleukin-1beta posttranslational processing
The eyes are often where it shows first
The EPA component specifically reduces inflammatory markers like C-reactive protein, which commonly elevates during the first 6 months of TRT
Be wary of any site that guarantees medication access without clinical review, uses vague pharmacy information, or sells investigational peptides such as retatrutide outside a clinical trial